Dah Sing's announcement in relation to the accounting treatment of the BOCQ
Man-cheong
12/05/2017
Up to 30 June 2017, the VIU has been above the Carrying Value, and hence no impairment charge has been made. However, in recent periods, whilst the Carrying Value has continued to increase, due to the profit contribution made by BOCQ, the VIU has decreased leading to a narrowing in the difference between the VIU and the Carrying Value. It is therefore possible that in future 1
assessments, the VIU may fall below the Carrying Value, in which case an impairment charge may become necessary in the financial results of DSB, DSBG and DSFH as set out above.
Shareholders and potential investors are reminded that no decision has yet been made as to whether an impairment charge to the Investment will be necessary, or if so, the quantum of any such impairment charge. Up to and including 30 June 2017, the VIU was still above the Carrying Value. However, in view of the narrowing of the difference between VIU and Carrying Value over time, further information to ensure that shareholders are aware of the accounting treatment as regards the Group’s investment in BOCQ was felt to be relevant information.
Link Dah Sing
assessments, the VIU may fall below the Carrying Value, in which case an impairment charge may become necessary in the financial results of DSB, DSBG and DSFH as set out above.
Shareholders and potential investors are reminded that no decision has yet been made as to whether an impairment charge to the Investment will be necessary, or if so, the quantum of any such impairment charge. Up to and including 30 June 2017, the VIU was still above the Carrying Value. However, in view of the narrowing of the difference between VIU and Carrying Value over time, further information to ensure that shareholders are aware of the accounting treatment as regards the Group’s investment in BOCQ was felt to be relevant information.
Link Dah Sing
訂閱:
張貼留言 (Atom)
沒有留言:
張貼留言